🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr Tineke Dixon sharing her powerful experience thriving as a >20 year heart-lung transplant survivor! A powerful charge to all of us in the field: what are we doing to understand and promote longterm survival for thoracic transplant recipients? #ISHLT2025 The ISHLT

Risk factors for post 🫀🫁 #TXP #ECMO support The ISHLT ➡️ECMO at listing ➡️Hx prior solid organ TXP ➡️Donor ischemic time > 4 hrs   ⭐️ Patients requiring ECMO at 72 hours following combined HLTx are at ⬆️ risk of post-TXP mortality

Congrats to our #LVAD team for its 500th #LVAD implant. Striving and innovating to save and improve quality of life

⭐What are the clinical features, and outcomes of #left_main #SCAD?🫀 Check out this interview🎥 with Alessandro Beneduce discussing their important #JACCINT manuscript👇🏽 jacc.org/doi/10.1016/j.… #CardioX #ACCFIT JACC Journals

New JACC Journals #JACCHF @unic_cardiovas   The EXIT-HF trial supports Home-Based Cardiac Rehab in optimally treated #HF patients 🫀 ➡️May provide an approach to overcome participation barriers in the traditional rehab setting   DOI: 10.1016/j.jchf.2024.09.024

Are we inching closer to GLP-1RA in HFrEF? New in #JACCHF, JACC Journals , a real-life study showed decrease in CV mortality in patients with HF, esp in overweight/obese with #HFrEF 💥Upcoming 5th pillar of #GDMT? jacc.org/doi/full/10.10… editorial: jacc.org/doi/10.1016/j.…

#JACC HF: From the CABANA trial: Patients with #HFpEF benefited > from #Afib ablation: ⬇️Death/CV hospitalization ⬇️AF recurrence Despite greater benefit of HFpEF patients, their risk of recurrence remained higher than in those without HFpEF shorturl.at/3F9aa

#HeartFailure continues to be a growing burden, also in the US, beautifully presented by BiykemBozkurt: 📍 Younger adults (35–64 yrs) show a greater relative annual increase in HF-related mortality than older adults🧑🏻‍⚕️👨🏻‍⚕️ 📍 Highest HF death rates reported in Midwest & Southern

The International Society for Heart and Lung Transplantation (ISHLT) recommends transitioning patients to mammalian targets of rapamycin inhibitors, such as sirolimus. #Immunosuppression #HeartTransplant Andrew (Drew) Rosenbaum, M.D. mayocl.in/3S9sY0Y

Are you under 40 & passionate about #heartfailure? Join the HFA Young community, open to all HFA Members under 40! As part of this vibrant network, you’ll gain access to tailored educational resources, career development opportunities, & initiatives designed to support the next

Thankful for opportunities from Mayo Clinic Rochester Cardiology Fellows 🫀

New in #JACCHF JACC Journals, in-hospital exercise-based cardiac rehab for pts admitted with #ADHF ➡️improvement in 6MWD, QoL, strength, & cognitive function without compromising safety. Early exercise/rehab FTW! 👀: jacc.org/doi/10.1016/j.… Editorial: jacc.org/doi/10.1016/j.…

New brief report in JACC Journals #JACCHF evaluating feasibility of withdrawing #GDMT and keeping pts w/ HFimpEF (EF <40 hx➡️ >50) just on carvedilol (50 mg/day) ✅ no sig difference in HF/EF at 52 weeks Opposing trial results vs. TRED-HF? 📎 jacc.org/doi/10.1016/j.…

New JACC Journals #JACCHF   ⭐️Clinical profiles & occurrence of SCD by #HCM phenotype ⭐️Performance validation of current guidelines doi: 10.1016/j.jchf.2024.12.006.

Did you see the studies presented in #ISHLTJournalWatch by #ISHLTEarlyCareer and trainee investigators?

New in #JACCHF JACC Journals, direct to physician communication by industry led to increased uptake of ARNI and SGLT2i but not BB, ACE/ARB or MRA. What happens when SGLT2i and ARNI are generic? All #GDMT saves lives! #GDMTworks jacc.org/doi/10.1016/j.…

New JACC Journals #JACCHF @AmmariatiEnrico Assessment of #stroke in #HFrEF 🫀   ⭐️Despite under reporting, stroke incidence is non-negligeable  ‼️Need for future studies to address this debilitating comorbidity   DOI: 10.1016/j.jchf.2024.12.008

New in JACC HF: Eplerenone decreased diffuse myocardial fibrosis in non-obstructive HCM.

New paper in JACC Journals #JACCHF by Stratton Tolmie William F Parker, MD, PhD The University of Chicago on the net survival benefit of the 2018 Heart Tx Allocation System One definitive success: improved allocation to higher acuity pts vs. prior system More work to be done! 📎 jacc.org/doi/10.1016/j.…